| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |